Ben Yong insider trades
Ben Yong has filed 12 Form 4s with the SEC that we hold, for Corbus Pharmaceuticals Holdings, Inc. (CRBP) (Director) and BridgeBio Oncology Therapeutics, Inc. (BBOT) (Chief Med & Dev Officer). Across all of them we count 0 purchases worth $0 and 1 sale worth $15.7K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($15.7K). The largest single trade was a sale of 2,000 shares of Corbus Pharmaceuticals Holdings, Inc. worth $15.7K, dated 2026-09-14. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2023-03-07 and the latest 2026-10-05.
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-09-14 | S, sale reported on Form 4 | 2,000 | $15.7K | 2026-09-15 |
BridgeBio Oncology Therapeutics, Inc. (BBOT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1967669) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms